Please login to the form below

Not currently logged in

AAA board presses go on $3.9bn Novartis takeover

Novartis HQFrench radiopharmaceuticals firm backs the cash offer

AZ pushes harder into China with new joint venture

AstraZeneca AZThe Anglo-Swedish group creates a new pharmaceutical business with the Chinese FIIF

MSD to create strong UK discovery centre in London

Merck & Co HQThe pharma group aims to start operations by 2020

AZ prices severe asthma drug Fasenra below competition

AstraZeneca AZThe discounted drug will cost $38,000 in the first year

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

Bayer - research centre BerlinThe German pharma group will gain full rights to the drugs outside the US

Fujifilm expands biopharma development and manufacturing business

SiteCompany invests 3.2bn yen in US and UK sites

Sanofi licences Principia MS drug in $805m deal

Sanofi receptionCalifornian biotech is set to receive $765m plus in milestone payments if PRN2246 goes to market

QuintilesIMS changes its name to IQVIA

IQVIAFirm will focus on human data science solutions

Ho_Ung_KimStanding out in a crowd

Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...